Article
Differentiated In Vitro Efficacy of BYL719, ARQ092, and Rapamycin on Fibroblasts Isolated From a Chinese PIK3CA-Related Overgrowth Spectrum Individual With a Novel Variant.
American journal of medical genetics. Part A - 1 Jul 2026
Xiong Fei, Wang Qian, Wang Shi-Qi, Zheng Miao, Zhong Hai-Yan, Zou Ming-Li, Yuan Si-Ming
Abstract excerpt
Postzygotic mutations of the PIK3CA gene constitutively activate the PI3K/AKT/mTOR pathway in patients with PIK3CA-related overgrowth spectrum (PROS), causing congenital mosaic tissue overgrowth. We established primary fibroblast cells from a patient with a novel somatic frameshift mutation (c.3190_3191insA, [p.H1065fs]) in PIK3CA, in which PI3K/AKT/mTOR signaling is activated compared to control fibroblasts. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
